Insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Diabetologia

• Publication date

  1998-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s001250050958PMID 9662040
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet Resistance to Nitrates in Obesity and Obese NIDDM, and Normal Platelet Sensitivity to Both Insulin and Nitrates in Lean NIDDM

  1998cited by this paper
• Nitric oxide released from activated platelets inhibits platelet recruitment.

  1997cited by this paper
• Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology.

  1997cited by this paper
• Influence of protamine on adhesion, chemotaxis and proliferation of human vascular smooth muscle cells

  1997cited by this paper
• Altered intracellular calcium and phorbol 12,13-dibutyrate binding to intact platelets in young obese subjects.

  1997cited by this paper
• Insulin Stimulates Nitric Oxide Synthesis in Human Platelets and, Through Nitric Oxide, Increases Platelet Concentrations of Both Guanosine-3′, 5′-Cyclic Monophosphate and Adenosine-3′, 5′-Cyclic Monophosphate

  1997cited by this paper
• Studies on the influence of insulin on cyclic adenosine monophosphate in human vascular smooth muscle cells: dependence on cyclic guanosine monophosphate and modulation of catecholamine effects

  1996cited by this paper
• Distribution and Activation of cAMP- and cGMP-Dependent Protein Kinases in Highly Purified Human Platelet Plasma and Intracellular Membranes

  1996cited by this paper
• In vivo effect of insulin on intracellular calcium concentrations: relation to insulin resistance.

  1996cited by this paper
• Effects of nitric oxide/EDRF on platelet surface glycoproteins.

  1996cited by this paper
• Prostacyclin and Sodium Nitroprusside Inhibit the Activity of the Platelet Inositol 1,4,5-Trisphosphate Receptor and Promote Its Phosphorylation (*)

  1996cited by this paper
• The Insulin-Induced Increase of Guanosine-3′,5′-Cyclic Monophosphate in Human Platelets Is Mediated by Nitric Oxide

  1996cited by this paper
• Role of catecholamines in platelet function: pathophysiological and clinical significance

  1996cited by this paper
• Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.

  1996cited by this paper
• Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.

  1996cited by this paper
• Effects of a Physiological Insulin Concentration on the Endothelin-Sensitive Ca2+ Store in Porcine Coronary Artery Smooth Muscle

  1996cited by this paper
• Insulin exerts opposite effects on platelet function at physiological and supraphysiological concentrations.

  1996cited by this paper
• Effects of insulin on calcium metabolism and platelet aggregation.

  1996cited by this paper
• Loss of high-affinity prostacyclin receptors in platelets and the lack of prostaglandin-induced inhibition of platelet-stimulated thrombin generation in subjects with spinal cord injury.

  1996cited by this paper
• Effects of Insulin and IGF-I on Vascular Smooth Muscle Glucose and Cation Metabolism

  1996cited by this paper
• Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture

  1996cited by this paper
• Variable effects of L-arginine analogs on L-arginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoforms.

  1996cited by this paper
• Treatment of non-insulin-dependent diabetic hypertensive patients with Ca2+ channel blockers is associated with increased platelet sensitivity to insulin.

  1995cited by this paper
• Inhibitory effects of insulin on cytosolic Ca2+ level and contraction in the rat aorta. Endothelium-dependent and -independent mechanisms.

  1995cited by this paper
• Nitric oxide release from resting human platelets.

  1995cited by this paper
• Regulatory and catalytic domains of platelet cAMP phosphodiesterases: targets for drug design.

  1995cited by this paper
• Hormonal regulation of the Na(+)-K(+)-ATPase: mechanisms underlying rapid and sustained changes in pump activity.

  1995cited by this paper
• Recent progress in understanding the hormonal regulation of phosphodiesterases.

  1995cited by this paper
• Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.

  1995cited by this paper
• Insulin-induced release of plasminogen activator from human blood platelets.

  1995cited by this paper
• Impaired Insulin-Induced Platelet Antiaggregating Effect in Obesity and In obese NIDDM Patients

  1995cited by this paper
• Expression of constitutive endothelial nitric oxide synthase in human blood platelets.

  1995cited by this paper
• Insulin inhibits dog vascular smooth muscle contraction and lowers Ca2+i by inhibiting Ca2+ influx.

  1995cited by this paper
• Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone

  1995cited by this paper
• Regulatory and catalytic domains of platelet cAMP phosphodiesterases: targets for drug design.

  1995cited by this paper
• Why is insulin not a risk factor for coronary heart disease?

  1994cited by this paper
• Insulin attenuates intracellular calcium responses and cell contraction caused by vasoactive agents.

  1994cited by this paper
• Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle

  1994cited by this paper
• Insulin Increases Guanosine-3′ ,5′-Cyclic Monophosphate in Human Platelets: A Mechanism Involved in the Insulin Anti-Aggregating Effect

  1994cited by this paper
• Insulin-induced Ca2+ transport is altered in vascular smooth muscle cells of spontaneously hypertensive rats.

  1994cited by this paper
• Hyperinsulinaemia and Na+, K+ ‐ATPase activity in thyrotoxic periodic paralysis

  1994cited by this paper
• Diabetes mellitus: a disease of abnormal cellular calcium metabolism?

  1994cited by this paper
• Receptor occupancy regulates Ca2+ entry and intracellular Ca2+ redistribution in activated human platelets.

  1994cited by this paper
• Nitric oxide synthase inhibition and platelet function.

  1994cited by this paper
• Nitric oxide inhibits neuronal nitric oxide synthase by interacting with the heme prosthetic group. Role of tetrahydrobiopterin in modulating the inhibitory action of nitric oxide.

  1994cited by this paper
• Signal transduction and regulation in smooth muscle

  1994cited by this paper
• Relaxant mechanisms of cyclic AMP-increasing agents in porcine coronary artery.

  1994cited by this paper
• Effects of forskolin and organic nitrate on aggregation and intracellular cyclic nucleotide content in human platelets.

  1994cited by this paper
• Isolation of nitric oxide synthase from human platelets.

  1994cited by this paper
• Insulin increases the aggregation response of human platelets to ADP.

  1994cited by this paper
• Transient Decrease of Binding of Insulin to Platelets in Acute Ischemic Heart Disease

  1994cited by this paper
• The insulin resistance syndrome: the controversy is dead, long live the controversy!

  1994cited by this paper
• The effects of in vitro and in vivo exposure to insulin upon prostaglandin E1 stimulation of platelet adenylate cyclase activity in healthy subjects.

  1994cited by this paper
• Insulin mediated processes in platelets, erythrocytes and monocytes/macrophages: effects of essential fatty acid metabolism.

  1994cited by this paper
• Insulin Attenuates Agonist‐Evoked Calcium Transients in Vascular Smooth Muscle Cells

  1994cited by this paper
• Insulin Inhibits Serotonin‐ Induced Ca2+ Influx in Vascular Smooth Muscle

  1994cited by this paper
• Stimulation of vascular Na(+)-K(+)-ATPase activity by nitric oxide: a cGMP-independent effect.

  1994cited by this paper
• Ca2+ influx in platelets: activation by thrombin and by the depletion of the stores. Effect of cyclic nucleotides.

  1994cited by this paper
• Blunted inhibition by insulin of agonist‐stimulated calcium, pH and aggregatory responses in platelets from hypertensive patients

  1994influential reference
• Why can high insulin levels indicate a risk for coronary heart disease?

  1994cited by this paper
• Platelet Plasminogen Activator Inhibitor 1 in Patients With Type II Diabetes

  1994cited by this paper
• Platelet calcium handling in spontaneously hypertensive rats and in three strains of normotensive rats

  1993cited by this paper
• Direct electrochemical measurement of nitric oxide released from human platelets.

  1993cited by this paper
• INSULIN INHIBITS VASOPRESSIN-ELICITED CONTRACTION OF VASCULAR SMOOTH MUSCLE CELLS

  1993cited by this paper
• Regulation of Na+,K(+)-ATPase gene expression by insulin in vascular smooth muscle cells.

  1993cited by this paper
• Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle.

  1993cited by this paper
• Insulin increases intracellular magnesium transport in human platelets.

  1993cited by this paper
• Insulin and atherosclerosis: villain, accomplice, or innocent bystander?

  1993cited by this paper
• Regulation of Ca2+ channels by cAMP and cGMP in vascular smooth muscle cells.

  1993cited by this paper
• Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost.

  1993cited by this paper
• Increased platelet cytosolic calcium responses to low density lipoprotein in type II diabetes with and without hypertension.

  1993cited by this paper
• Insulin attenuates agonist-mediated calcium mobilization in cultured rat vascular smooth muscle cells.

  1993cited by this paper
• Na+—Ca2+ exchange modulates Ca2+ handling of human platelets by altering intracellular Ca2+ store size

  1993cited by this paper
• Intracellular and extracellular magnesium depletion in Type 2 (non-insulin-dependent) diabetes mellitus

  1993cited by this paper
• Insulin increases vascular smooth muscle recovery from intracellular calcium loads.

  1993cited by this paper
• Vascular insulin abnormalities, hypertension, and accelerated atherosclerosis.

  1993cited by this paper
• Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis.

  1993cited by this paper
• Stimulation by insulin of a serine kinase in human platelets that phosphorylates and activates the cGMP-inhibited cAMP phosphodiesterase.

  1993influential reference
• Inhibition of platelet aggregation and the stimulation of prostacyclin synthesis by insulin in humans.

  1993cited by this paper
• Inhibition by nitroprusside of platelet calcium mobilization: evidence for reduced sensitivity to nitric oxide in essential hypertension

  1993cited by this paper
• Phosphorylation and subcellular translocation of endothelial nitric oxide synthase.

  1993cited by this paper
• Insulin attenuation of vasopressin-induced calcium responses in arterial smooth muscle from Zucker rats.

  1993cited by this paper
• Decreased insulin-sensitive Ca2+ transport in cultured vascular smooth muscle cells from spontaneously hypertensive rats.

  1992cited by this paper
• Cyclic AMP stimulates Ca(2+)-ATPase-mediated Ca2+ extrusion from human platelets.

  1992cited by this paper
• Stimulation of dense tubular Ca2+ uptake in human platelets by cAMP.

  1992cited by this paper
• Cyclic nucleotides attenuate thrombin-evoked alterations in parameters of platelet Na/H antiport. The role of cytosolic Ca.

  1992cited by this paper
• Nitric Oxide Functions as an Inhibitor of Platelet Adhesion Under Flow Conditions

  1992cited by this paper
• Insulin attenuates vasoconstriction by noradrenaline, serotonin and potassium chloride in rat mesenteric arterioles.

  1992cited by this paper
• Normalization of impaired response of platelets to prostaglandin E1/I2 and synthesis of prostacyclin by insulin in unstable angina pectoris and in acute myocardial infarction.

  1992cited by this paper
• Down regulation of α2 adrenergic receptor numbers in platelets by insulin

  1992cited by this paper
• Diabetes mellitus and hypertension.

  1992cited by this paper
• Molecular biology of dopamine receptors.

  1992cited by this paper
• Down regulation of alpha 2 adrenergic receptor numbers in platelets by insulin.

  1992cited by this paper
• Endothelium-dependent inhibition of Na(+)-K+ ATPase activity in rabbit aorta by hyperglycemia. Possible role of endothelium-derived nitric oxide.

  1992cited by this paper
• Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets.

  1992cited by this paper
• Effect of extracellular magnesium on platelet activation and intracellular calcium mobilization.

  1992cited by this paper
• Altered Platelet Function in Diabetes Mellitus: Effect of Glycemic Regulation and Antiplatelet Agents

  1992cited by this paper
• Rise and Fall of Agonist-Evoked Platelet Ca2+ in Hypertensive Rats

  1991cited by this paper
• Sodium-calcium exchange. Ins and outs of Ca2+ transport.

  1991cited by this paper
• Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells.

  1991cited by this paper

• Association of triglyceride-glucose index and its related parameters with the risk of stroke: a meta-analysis

  2025cites this paper
• Acute Antiplatelet Effects of an Oleocanthal-Rich Olive Oil in Type II Diabetic Patients: A Postprandial Study

  2024cites this paper
• The rate of platelet activation determines thrombus size and structure at arterial shear.

  2023cites this paper
• Thiazolidinediones (TZDs)

  2021cites this paper
• Platelet and white blood cell count are independently associated with sarcopenia: A nationwide population-based study.

  2019cites this paper
• 13.20 – Mechanisms of Drug-Induced Cardiovascular Toxicity: Cardiotoxicity Associated With Diabetes Medications☆

  2018cites this paper
• Platelet function and insulin resistance in aged and middle-aged obese female patients -

  2018cites this paper
• β-Adrenergic Receptor and Insulin Resistance in the Heart

  2017cites this paper
• Diabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic

  2016cites this paper
• Cardiovascular Manifestations of Diabetes Mellitus: A Narrative Review of Literatures

  2016cites this paper
• Postprandial activation of platelets as a possible mechanism for the development of atherosclerosis

  2016cites this paper
• [Results of Coronary Artery Bypass Surgery Combined With Endarterectomy and Reconstruction of Anterior Descending Artery in Patients With Diabetes Mellitus].

  2015cites this paper
• Diseases of the endocrine system

  2015cites this paper
• Effect of non-esterified fatty acids on insulin resistance and cardiovascular risk in polycystic ovary syndrome

  2013cites this paper
• The Prothrombotic Tendency in Metabolic Syndrome: Focus on the Potential Mechanisms Involved in Impaired Haemostasis and Fibrinolytic Balance

  2012cites this paper
• Mediterranean wild plants reduce postprandial platelet aggregation in patients with metabolic syndrome.

  2012cites this paper
• A Novel Small Molecule 1,2,3,4,6-penta-O-galloyl-α-D-glucopyranose Mimics the Antiplatelet Actions of Insulin

  2011cites this paper
• Effects of insulin on the vasculature.

  2011cites this paper
• Use of Metformin in Patients with Kidney and Cardiovascular Diseases

  2011cites this paper
• MAJOR DEPRESSION AND INSULIN RESISTANCE AMONG NONDIABETIC U.S. ADULTS AGED 20-39 YEARS: THE ROLES OF GENDER AND RACE/ETHNICITY

  2011cites this paper
• Cardiotoxicity Associated with Thiazolidinediones

  2010cites this paper
• Factors affecting metformin plasma concentrations

  2010cites this paper
• Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells

  2010influential citation
• Iconography : Quelle place pour l’aspirine en prévention cardiovasculaire primaire chez le diabétique en 2010 ?

  2010cites this paper
• From the American Heart Association Diabetes and Cardiovascular Disease : A Statement for Healthcare Professionals

  2010cites this paper
• Platelet aggregation responses in type 2 diabetic patients

  2010cites this paper
• In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin

  2010cites this paper
• Pathophysiology of the prothrombotic state in metabolic syndrome

  2009cites this paper
• Fisiopatología del estado protrombótico en el síndrome metabólico

  2009cites this paper
• Investigation of the genetic basis of insulin resistance and cardiovascular disease

  2009cites this paper
• Platelet dysfunction in central obesity.

  2009cites this paper
• Contribution of insulin resistance to vascular dysfunction

  2009influential citation
• Nitric Oxide Synthase in Pancreatic Islets

  2009cites this paper
• Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndrome.

  2008cites this paper
• Review Cardiovascular disease in diabetes : An enigma of dyslipidemia , thrombosis and inflammation

  2008cites this paper
• Metabolic syndrome, haemostasis and thrombosis

  2008cites this paper
• Metabolic consequences of hyperglycemia and insulin resistance.

  2007cites this paper
• High-dose folate may improve platelet function in acute coronary syndrome and other pathologies associated with increased platelet oxidative stress.

  2007cites this paper
• Expression of islet inducible nitric oxide synthase and inhibition of glucose-stimulated insulin release after long-term lipid infusion in the rat is counteracted by PACAP27.

  2007cites this paper
• Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein.

  2007cites this paper
• Insulin resistance and thrombogenesis: recent insights and therapeutic implications.

  2007cites this paper
• Diabetes mellitus as a prothrombotic condition

  2007cites this paper
• Inhibitory effect of insulin on vasopressin-induced intracellular calcium response is blunted in hyperinsulinemic hypertensive patients: role of membrane fatty acid composition

  2006cites this paper
• Platelet resistance to the anti-aggregating agents in the insulin resistant states.

  2006cites this paper
• Effect of L-carnitine on acetyl-CoA content and activity of blood platelets in healthy and diabetic persons.

  2005cites this paper
• IRS-1 and vascular complications in diabetes mellitus.

  2005cites this paper
• Pathophysiology of Insulin Action in Humans

  2005cites this paper
• Type 2 diabetes: an atherothrombotic syndrome.

  2005cites this paper
• High glucose rapidly activates the nitric oxide/cyclic nucleotide pathway in human platelets via an osmotic mechanism

  2005cites this paper
• Auswirkungen eines ausgeprägten Gewichtsverlusts auf intramyozelluläre Lipideinlagerungen, metabolische Parameter und kardiovaskuläre Risikofaktoren

  2005cites this paper
• Identifying pathways involved in leptin-dependent aggregation of human platelets

  2004cites this paper
• Glycoprotein IIb/IIIa inhibition enhances platelet nitric oxide release.

  2004cites this paper
• Zusammenhang zwischen Plasmaadiponektinspiegel und Insulinwirkung auf Glukose-und Fettstoffwechsel

  2004cites this paper
• Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity

  2004cites this paper
• Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance

  2004cites this paper
• IRS-1 Mediates Inhibition of Ca2+ Mobilization by Insulin via the Inhibitory G-protein Gi*

  2004cites this paper
• Chapter 2 Primary Prevention of Stroke by Modification of Selected Risk Factors

  2004cites this paper
• Vascular and Platelet Function in Insulin Resistance

  2004cites this paper
• Nitric Oxide Synthase in Pancreatic Islets During Trauma and Parenteral Feeding Qader, Saleem

  2004cites this paper
• Total parenteral nutrition-stimulated activity of inducible nitric oxide synthase in rat pancreatic islets is suppressed by glucagon-like peptide-1.

  2003cites this paper
• Vascular effects of insulin. A clinical physiologist's viewpoint

  2003cites this paper
• Leptin-dependent platelet aggregation in healthy, overweight and obese subjects

  2003cites this paper
• Platelet dysfunction in lean women with polycystic ovary syndrome and association with insulin sensitivity.

  2003cites this paper
• Comparison between the effects of the rapid recombinant insulin analog Lispro (Lys B28, Pro B29) and those of human regular insulin on platelet cyclic nucleotides and aggregation.

  2003cites this paper
• Total Parenteral Nutrition-Stimulated Activity of Inducible Nitric Oxide Synthase in Rat Pancreatic Islets is Suppressed by Glucagon-Like Peptide-1

  2003cites this paper
• Nonglycemic effects of insulin.

  2003cites this paper
• Profilaktyka i leczenie trombofilii cukrzycowej w świetle najnowszych badań

  2003cites this paper
• Inhibition of Platelet‐Collagen Interaction An In Vivo Action of Insulin Abolished by Insulin Resistance in Obesity

  2002cites this paper
• Platelet Nitric Oxide and Superoxide Release During the Development of Nitrate Tolerance: Effect of Supplemental Ascorbate

  2002cites this paper
• Metformin: An Update

  2002cites this paper
• Effects of insulin on platelet and leukocyte activity in whole blood.

  2002cites this paper
• Diabetes and cardiovascular disease.

  2002cites this paper
• Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function.

  2002cites this paper
• Production of 8-epi prostaglandin F(2alpha) in human platelets during administration of organic nitrates.

  2002cites this paper
• Glitazones: clinical effects and molecular mechanisms

  2002cites this paper
• The Arg200Trp Mutation in the Human Tissue Factor Gene

  2002cites this paper
• Catecholamines, via beta-adrenoceptors, increase intracellular concentrations of 3',5'-cyclic guanosine monophosphate (cGMP) through nitric oxide in human platelets.

  2002cites this paper
• Hypertension plus diabetes mimics the cardiomyopathy induced by nitric oxide inhibition in rats.

  2002cites this paper
• Insulin resistance and risk for stroke

  2002cites this paper
• Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation.

  2002cites this paper
• Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients.

  2001cites this paper
• Insulin Resistance and Insulin Sensitizers

  2001cites this paper
• Insulin and heregulin-β1 upregulate guanylyl cyclase C expression in rat hepatocytes

  2001cites this paper
• N‐acetyl‐L‐cysteine exerts direct anti‐aggregating effect on human platelets

  2001cites this paper
• [Effects of ethanol on the nervous and vascular systems: the mechanisms of alcohol-induced hypertension].

  2001cites this paper
• Total parenteral nutrition modulates hormone release by stimulating expression and activity of inducible nitric oxide synthase in rat pancreatic islets

  2001cites this paper
• Preventing Cardiovascular Complications of Type 2 Diabetes: Focus on Lipid Management

  2001cites this paper
• Insulin sensitivity regulates autonomic control of heart rate variation independent of body weight in normal subjects.

  2001cites this paper
• Obesity Inhibition of Platelet-Collagen Interaction : An In Vivo Action of Insulin Abolished

  2001cites this paper
• Clinical features of insulin resistance and beta cell dysfunction and the relationship to type 2 diabetes.

  2001cites this paper
• Insulin and heregulin-beta1 upregulate guanylyl cyclase C expression in rat hepatocytes: reversal by phosphodiesterase-3 inhibition.

  2001cites this paper
• Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content.

  2001cites this paper
• Effects of Insulin on the Kidney and the Cardiovascular System

  2000cites this paper
• Dysfunction of the Vascular Endothelium and the Development of Renal and Vascular Complications in Diabetes

  2000cites this paper
• Management of Type 2 Diabetes Mellitus and Cardiovascular Risk

  2000cites this paper
• Human vascular smooth muscle cells express a constitutive nitric oxide synthase that insulin rapidly activates, thus increasing guanosine 3′ : 5′-cyclic monophosphate and adenosine 3′ : 5′-cyclic monophosphate concentrations

  1999cites this paper
• Insulin: new roles for an ancient hormone

  1999cites this paper
• Evidence for iNOS-dependent peroxynitrite production in diabetic platelets

  1999cites this paper
• [Platelet aggregation inhibitors in diabetes mellitus].

  1999cites this paper
• Insulin Resistance and Blood Pressure

  1999cites this paper